China Regenerative Medicine International Limited

SEHK:8592 Stock Report

Market Cap: HK$188.4m

China Regenerative Medicine International Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 8592?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders72,222,50025.3%
Private Companies100,554,77735.2%
General Public112,651,67339.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 7 shareholders own 60.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.4%
All Favour Holdings Limited
58,254,777HK$38.4m0%no data
19.3%
Chuang Wang
55,052,000HK$36.3m0%no data
9.19%
Changzhou Yaoguang Enterprise Management Consulting Limited Liability Partnership
26,240,000HK$17.3m0%no data
5.63%
Changzhou Zhongmin Xingkong Business Management Consulting Service Partnership Enterprise
16,060,000HK$10.6m0%no data
5.24%
Xiaogang Wang
14,945,000HK$9.9m0%no data
0.75%
Ren Li
2,138,000HK$1.4m0%no data
0.031%
Yumin Dai
87,500HK$57.8k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.